University of Virginia Comprehensive Cancer Center scientists have developed a promising new experimental approach to targeting glioblastoma, the most common and deadliest brain cancer.
Researchers have developed a breath detector with a chemical sensor that sniffs out when your body is burning fat through a single exhale. Reporting in Device, the handheld, smartphone-assisted device measures acetone—a molecule that is released into the breath when the body burns fat—in about 90 seconds with laboratory-level accuracy.
Implanted medical devices are instruments placed surgically in the body. Many are battery-powered or can be wirelessly recharged. While they can be lifesavers, they are not without problems. They can run out of battery power, and wireless methods for transferring power and data have technical limitations.
Clinical case study challenges established paradigms on permanent cognitive and motor decline in age-related degenerative diseases.
Capsules containing donor stool microbes improved sleep efficiency and reduced nighttime wakefulness in adults with chronic insomnia.
Personalized genetic therapy helped researchers treat two children with a rare form of epilepsy, enabling one to walk independently for the first time.
Prions can turn the body’s own proteins into a threat, and studying this group of diseases could help us better understand dementia.
The FDA announced today that it selected Dexcom (Nasdaq:DXCM) as the first manufacturer for a new digital health pilot.
Johnson & Johnson (NYSE:JNJ) announced today that it received FDA de novo authorization for its Ottava surgical robot system.